Univo Pharmaceuticals (XTAE:UNVO-M) Other Net Income (Loss) : ₪0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Other Net Income (Loss)?

Univo Pharmaceuticals's Other Net Income (Loss) for the three months ended in Jun. 2022 was ₪0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 was ₪0.00 Mil.

Univo Pharmaceuticals's annual Other Net Income (Loss) declined from Dec. 2019 (₪0.00 Mil) to Dec. 2020 (₪0.00 Mil) and declined from Dec. 2020 (₪0.00 Mil) to Dec. 2021 (₪0.00 Mil).

Univo Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Univo Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals Other Net Income (Loss) Chart

Univo Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Net Income (Loss)

Get a 7-Day Free Trial

Univo Pharmaceuticals Quarterly Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Other Net Income (Loss)	Get a 7-Day Free Trial													-	-	-	-	-

Univo Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

Univo Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Univo Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harshar 20, Ashkelon, ISR, 7878329

Website

https://www.univopharma.com

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines